Rajan A[au] - Search Results

Year	Number of Results
1965	2
1966	1
1968	1
1970	1
1971	1
1974	1
1978	1
1980	1
1981	4
1982	5
1983	4
1984	1
1985	1
1986	1
1987	3
1988	2
1989	4
1990	2
1991	4
1992	3
1993	4
1994	2
1995	1
1996	2
1997	1
1998	3
1999	2
2000	2
2001	2
2003	3
2004	1
2005	3
2006	4
2007	7
2008	14
2009	10
2010	15
2011	17
2012	14
2013	22
2014	23
2015	26
2016	22
2017	28
2018	24
2019	37
2020	40
2021	30

1

Oral decontamination techniques and ventilator-associated pneumonia.

Chacko R, Rajan A, Lionel P, Thilagavathi M, Yadav B, Premkumar J. Chacko R, et al. Among authors: rajan a. Br J Nurs. 2017 Jun 8;26(11):594-599. doi: 10.12968/bjon.2017.26.11.594. Br J Nurs. 2017. PMID: 28594615 Clinical Trial.

2

γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.

Pont MJ, Hill T, Cole GO, Abbott JJ, Kelliher J, Salter AI, Hudecek M, Comstock ML, Rajan A, Patel BKR, Voutsinas JM, Wu Q, Liu L, Cowan AJ, Wood BL, Green DJ, Riddell SR. Pont MJ, et al. Among authors: rajan a. Blood. 2019 Nov 7;134(19):1585-1597. doi: 10.1182/blood.2019000050. Blood. 2019. PMID: 31558469 Free PMC article.

3

The Integrated Genomic Landscape of Thymic Epithelial Tumors.

Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, McLellan M, Bowlby R, Matthew T, Danilova L, Hegde AM, Kim J, Leiserson MDM, Sethi G, Lu C, Ryan M, Su X, Cherniack AD, Robertson G, Akbani R, Spellman P, Weinstein JN, Hayes DN, Raphael B, Lichtenberg T, Leraas K, Zenklusen JC; Cancer Genome Atlas Network, Fujimoto J, Scapulatempo-Neto C, Moreira AL, Hwang D, Huang J, Marino M, Korst R, Giaccone G, Gokmen-Polar Y, Badve S, Rajan A, Ströbel P, Girard N, Tsao MS, Marx A, Tsao AS, Loehrer PJ. Radovich M, et al. Among authors: rajan a. Cancer Cell. 2018 Feb 12;33(2):244-258.e10. doi: 10.1016/j.ccell.2018.01.003. Cancer Cell. 2018. PMID: 29438696 Free PMC article.

4

Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.

Balakrishnan A, Goodpaster T, Randolph-Habecker J, Hoffstrom BG, Jalikis FG, Koch LK, Berger C, Kosasih PL, Rajan A, Sommermeyer D, Porter PL, Riddell SR. Balakrishnan A, et al. Among authors: rajan a. Clin Cancer Res. 2017 Jun 15;23(12):3061-3071. doi: 10.1158/1078-0432.CCR-16-2083. Epub 2016 Nov 16. Clin Cancer Res. 2017. PMID: 27852699 Free PMC article.

5

Designed protein logic to target cells with precise combinations of surface antigens.

Lajoie MJ, Boyken SE, Salter AI, Bruffey J, Rajan A, Langan RA, Olshefsky A, Muhunthan V, Bick MJ, Gewe M, Quijano-Rubio A, Johnson J, Lenz G, Nguyen A, Pun S, Correnti CE, Riddell SR, Baker D. Lajoie MJ, et al. Among authors: rajan a. Science. 2020 Sep 25;369(6511):1637-1643. doi: 10.1126/science.aba6527. Epub 2020 Aug 20. Science. 2020. PMID: 32820060 Free PMC article.

6

Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy.

Warner BM, Baer AN, Lipson EJ, Allen C, Hinrichs C, Rajan A, Pelayo E, Beach M, Gulley JL, Madan RA, Feliciano J, Grisius M, Long L, Powers A, Kleiner DE, Cappelli L, Alevizos I. Warner BM, et al. Among authors: rajan a. Oncologist. 2019 Sep;24(9):1259-1269. doi: 10.1634/theoncologist.2018-0823. Epub 2019 Apr 17. Oncologist. 2019. PMID: 30996010 Free PMC article.

7

Features of the biochemistry of Mycobacterium smegmatis, as a possible model for Mycobacterium tuberculosis.

T JAS, J R, Rajan A, Shankar V. T JAS, et al. Among authors: rajan a. J Infect Public Health. 2020 Sep;13(9):1255-1264. doi: 10.1016/j.jiph.2020.06.023. Epub 2020 Jul 13. J Infect Public Health. 2020. PMID: 32674978 Free article. Review.

8

Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.

Salter AI, Ivey RG, Kennedy JJ, Voillet V, Rajan A, Alderman EJ, Voytovich UJ, Lin C, Sommermeyer D, Liu L, Whiteaker JR, Gottardo R, Paulovich AG, Riddell SR. Salter AI, et al. Among authors: rajan a. Sci Signal. 2018 Aug 21;11(544):eaat6753. doi: 10.1126/scisignal.aat6753. Sci Signal. 2018. PMID: 30131370 Free PMC article.

9

Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma.

Rajan A, Heery CR, Thomas A, Mammen AL, Perry S, O'Sullivan Coyne G, Guha U, Berman A, Szabo E, Madan RA, Ballester LY, Pittaluga S, Donahue RN, Tsai YT, Lepone LM, Chin K, Ginty F, Sood A, Hewitt SM, Schlom J, Hassan R, Gulley JL. Rajan A, et al. J Immunother Cancer. 2019 Oct 21;7(1):269. doi: 10.1186/s40425-019-0723-9. J Immunother Cancer. 2019. PMID: 31639039 Free PMC article.

10

Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors.

Thomas A, Redon CE, Sciuto L, Padiernos E, Ji J, Lee MJ, Yuno A, Lee S, Zhang Y, Tran L, Yutzy W, Rajan A, Guha U, Chen H, Hassan R, Alewine CC, Szabo E, Bates SE, Kinders RJ, Steinberg SM, Doroshow JH, Aladjem MI, Trepel JB, Pommier Y. Thomas A, et al. Among authors: rajan a. J Clin Oncol. 2018 Jun 1;36(16):1594-1602. doi: 10.1200/JCO.2017.76.6915. Epub 2017 Dec 18. J Clin Oncol. 2018. PMID: 29252124 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results